• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

tetano

Editor, Senior Moderator
Nat Commun


. 2023 Apr 22;14(1):2329.
doi: 10.1038/s41467-023-37470-4.
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19


Urszula Radzikowska[SUP] 1 2 3 [/SUP], Andrzej Eljaszewicz[SUP] 1 2 3 [/SUP], Ge Tan[SUP] 1 4 [/SUP], Nino Stocker[SUP] 1 [/SUP], Anja Heider[SUP] 1 [/SUP], Patrick Westermann[SUP] 1 [/SUP], Silvio Steiner[SUP] 5 6 7 [/SUP], Anita Dreher[SUP] 1 2 [/SUP], Paulina Wawrzyniak[SUP] 1 2 8 9 [/SUP], Beate Rückert[SUP] 1 [/SUP], Juan Rodriguez-Coira[SUP] 1 10 11 [/SUP], Damir Zhakparov[SUP] 1 [/SUP], Mengting Huang[SUP] 1 [/SUP], Bogdan Jakiela[SUP] 12 [/SUP], Marek Sanak[SUP] 12 [/SUP], Marcin Moniuszko[SUP] 3 13 [/SUP], Liam O'Mahony[SUP] 1 14 [/SUP], Marek Jutel[SUP] 15 16 [/SUP], Tatiana Kebadze[SUP] 17 18 [/SUP], J David Jackson[SUP] 19 20 [/SUP], R Michael Edwards[SUP] 17 21 [/SUP], Volker Thiel[SUP] 5 22 [/SUP], L Sebastian Johnston[SUP] 17 21 23 [/SUP], A Cezmi Akdis[SUP] #[/SUP][SUP] 1 2 [/SUP], Milena Sokolowska[SUP] #[/SUP][SUP] 24 25 [/SUP]



Affiliations

Abstract

Rhinoviruses and allergens, such as house dust mite are major agents responsible for asthma exacerbations. The influence of pre-existing airway inflammation on the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely unknown. We analyse mechanisms of response to viral infection in experimental in vivo rhinovirus infection in healthy controls and patients with asthma, and in in vitro experiments with house dust mite, rhinovirus and SARS-CoV-2 in human primary airway epithelium. Here, we show that rhinovirus infection in patients with asthma leads to an excessive RIG-I inflammasome activation, which diminishes its accessibility for type I/III interferon responses, leading to their early functional impairment, delayed resolution, prolonged viral clearance and unresolved inflammation in vitro and in vivo. Pre-exposure to house dust mite augments this phenomenon by inflammasome priming and auxiliary inhibition of early type I/III interferon responses. Prior infection with rhinovirus followed by SARS-CoV-2 infection augments RIG-I inflammasome activation and epithelial inflammation. Timely inhibition of the epithelial RIG-I inflammasome may lead to more efficient viral clearance and lower the burden of rhinovirus and SARS-CoV-2 infections.
 
Back
Top Bottom